Cardiovascular disease in Cushing's syndrome: heart versus vasculature
Monica De Leo, Rosario Pivonello, Renata S Auriemma, Alessia Cozzolino, Pasquale Vitale, Chiara Simeoli, Maria Cristina De Martino, Gaetano Lombardi, Annamaria Colao, Monica De Leo, Rosario Pivonello, Renata S Auriemma, Alessia Cozzolino, Pasquale Vitale, Chiara Simeoli, Maria Cristina De Martino, Gaetano Lombardi, Annamaria Colao
Abstract
Cushing's syndrome (CS) causes metabolic abnormalities that determine an increased cardiovascular risk not only during the active phase of the disease but also for a long time after cure. Cardiovascular complications, such as premature atherosclerosis, coronary artery disease, heart failure, and stroke, in patients with CS cause a mortality rate higher than that observed in a normal population. The increased cardiovascular risk is mainly due to metabolic complications, such as metabolic syndrome, but also to vascular and cardiac alterations such as atherosclerosis and cardiac structural and functional changes. In the clinical management of patients with CS the focus should be on identifying the global cardiovascular risk and the aim should be to control not only hypertension but also other correlated risk factors, such as obesity, glucose intolerance, insulin resistance, dyslipidemia, endothelial dysfunction and the prothrombotic state. Considering that remission from hypercortisolism is often difficult to achieve and that the cardiovascular risk can persist even during disease remission, care and control of all cardiovascular risk factors should be one of the primary goals during the follow-up of these patients.
Copyright © 2010 S. Karger AG, Basel.
Source: PubMed